Purchase Order 75N98026P00556
Award Date 5/20/26
Potential Completion Date 6/19/26
Potential Value $25K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Jose, CA 95131, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services National Institutes of Health (NIH) Clinical Center awarded a firm fixed price purchase order to Takara Bio USA, Inc. to supply specialized reagents, including the RetroNectin product, to support cellular therapy manufacturing at the NIH Clinical Center. The $188,757.80 contract has a period of performance from March 1, 2019 to September 30, 2019 and is not designated as a set-aside. Takara Bio USA, Inc. is a for-profit manufacturer that has provided...
- The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $30,672 purchase order to Takara Bio Usa, Inc. for the delivery of RETRONECTIN GMP GRADE REAGENT. Performance will take place in San Jose, California over a period of approximately two months from December 2023 through February 2024. As the prime contractor, Takara Bio Usa, Inc. will provide the requested biomedical products to support the NIH Clinical Center's medical research efforts. No...
- The Department of Health and Human Services National Institutes of Health Clinical Center (NIH CC) awarded a firm fixed-price purchase order to Takara Bio USA, Inc. for the delivery of 154 vials of the RetroNectin reagent, which is used in the NIH CC's cellular therapy programs. This purchase order, valued at $188,796.30, was issued as a non-competitive award without full and open competition under simplified acquisition procedures. The NIH CC determined that Takara Bio USA, Inc. was the sole...
- This is a $11,916.60 firm fixed-price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Takara Bio USA, Inc., a for-profit manufacturer of biomedical products and life sciences research tools. The contract is for the supply of 2.5 ml of RetroNectin GMP grade, a critical reagent used in various cutting-edge scientific research areas supported by NIH, including COVID-19, genomics, cellular therapy, and other disciplines. The contract has no set-aside...
- Takara Bio USA, Inc. was awarded a firm fixed-price purchase order valued at forty-six thousand eight dollars by the Department of Health and Human Services' National Institutes of Health Clinical Center. Under this contract, Takara Bio will provide Retronectin GMP Grade Reagent to the agency. The place of performance is in San Jose, California and the period of performance concludes on February 9, 2024. No set-aside designation was applied to this award to procure the requested biomedical...
- This is a firm-fixed-price delivery order contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The contract, worth $12,600.00, was awarded to Takara Bio USA, Inc., a for-profit manufacturer of specialized biomedical products and services. The contract is for the provision of GMP (Good Manufacturing Practice) grade RetroNectin, a proprietary recombinant human fibronectin...
- This is a firm fixed-price delivery order awarded by the National Cancer Institute, a civilian agency within the U.S. Department of Health and Human Services, to Takara Bio USA, Inc. The contract is for the supply of RETRONECTIN (GMP GRADE), a specialized biomedical product used in advanced life sciences research and clinical applications. The award ceiling value is $37,800.00 and the ultimate completion date is August 28, 2015. The contract does not have a small business set-aside...
- Takara Bio Inc. was awarded a $5,200 purchase order by the National Institutes of Health (NIH) to deliver GMP grade CH-296 with certificate of analysis totaling 2.5 milligrams. The product will be delivered to Fabio Candotti at NIH's Bethesda, Maryland campus by May 30, 2009. As a small business set-aside, this firm fixed price contract supports NIH's ongoing biomedical research efforts through the targeted procurement of specialized compounds from commercial suppliers. No subcontractors were...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Takara Bio USA, Inc., a prominent provider of specialized biomedical products and services to the U.S. federal government. The contract, valued at $2,508.00, is for the supply of various genomics, cell biology, and molecular diagnostics tools, including products such as SmartScribe Reverse Transcriptase, SeqAmp DNA Polymerase, and RetroNectin GMP Grade Reagent. These products...
- Takara Bio USA, Inc. was awarded a $24,900.00 firm fixed-price purchase order contract by the National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases. The contract, which has a completion date of May 31, 2025, does not have a set-aside designation. As a prime contractor, Takara Bio USA, Inc. will provide specialized biomedical products and services to support NIH's research programs, including proprietary kits and reagents for single-cell...